T-cell co-stimulation by the CD28 ligand B7 is involved in the immune response leading to rejection of a spontaneously regressive tumor

International Journal of Cancer

Volumn 66, Issue 2, 1996, Pages 244-248

  Chaux, Pascal ^a   Martin, Monique S ^a   Martin, François ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER REGRESSION; CARCINOGENICITY; FEMALE; FLOW CYTOMETRY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; NEOPLASMS, EXPERIMENTAL; RATS; REMISSION, SPONTANEOUS; T-LYMPHOCYTES;

EID: 0029946299     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960410)66:2<244::AID-IJC18>3.0.CO;2-C     Document Type: Article

References (22)

1. BOON, T., Antigenic tumor cell variants obtained with mutagens. Advanc. Cancer Res , 39, 121-151 (1983).
2. BOUSSIOTIS, V.A., FREEMAN, G.J., GRIFFIN, J.D., GRAY, G.S., GRIBBEN, J.G. and NADLER, L.M., CD2 is involved in maintainance and reversal of human alloantigen-speciflc clonal anergy. J exp. Med , 180, 1665-1673 (1994).
3. CAIGNARD, A., MARTIN, M.S., MICHEL, M.F. and MARTIN, F., Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int. J. Cancer, 36, 273-279 (1985).
4. CHAUX, P., HAMMANN, A., MARTIN, F. and MARTIN, M., Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation. Europ. J. Immunol., 23, 2517-2525 (1993).
5. CORRELL, L.L., NIELSEN, L.D., KELLEHER, P.J., HARBELL, J.W. and MINDEN, P., Enhanced immunogenicity of Line 10 guinea pig hepatocarcinoma cells after culture. J. nat. Cancer Inst., 71, 1343-1346 (1983).
6. FROST, P., KERBEL, R.S., BAUER, E., TARTAMELLA-BIONDO, R. and CEFALU, W., Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant tumors. Cancer Res., 43, 125-132 (1983).
7. GUINAN, E.C., GRIBBEN, J.G., BOUSSIOTIS, V.A., FREEMAN, G.J. and NADLER, L.M., Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84, 3261-3282 (1984).
8. HARDING, F.A., MCARTHUR, J.G., GROSS, J.A., RAULET, D.H. and ALLISON, J.P., CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature (Lond.), 356, 607-609 (1992).
9. INABA, K., WITMER-PACK, M., INABA, M., HATCHOCK, K.S., SAKUTA, H., AZUMA, M., YAGITA, H., OKUMURA, K., LINSLEY, P.S., IKEHARA, S., MURAMATSU, S., HODES, R.J. and STEINMAN. R., The tissue distribution of the B7-2 co-stimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. exp. Med., 180, 1849-1860 (1994).
10. JANEWAY, C.A. and BOTTOMLY, K., Signals and signs for lymphocyte response. Cell, 76, 275-285 (1994).
11. JENKINS, M.K. and JOHNSON, J.G., Molecules involved in T cell costimulation. Curr. Opin. Immunol., 5, 361-367 (1993).
12. KLINKERT, W.E.F., LABADIE, J.H. and BOWERS, W.E., Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J. exp. Med., 156, 1-19 (1982).
13. LIN, H, BOLLING, S.F., LINSLEY, P.S., WEI, R.Q., GORDON, D., THOMPSON, C.B. and TURKA, L.A., Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor specific transfusion. J. exp. Med., 178, 1801-1806 (1993).
14. LINSLEY, P.S., WALLACE, P.M., JOHNSON, J., GIBSON, M.G , GREENE, J.L., LEDBETTER, J.A., SINGH, C. and TEPPER, M.A., Immunosuppression in vivo by a soluble form of the CTLA4Ig T cell activation molecule. Science (Wash.), 257, 792-795 (1992).
15. MARTIN, M.S., CAIGNARD, A., HAMMANN, A., PELLETIER, A. and MARTIN, F., An immunohistological study of cells infiltrating progressive and regressive tumors induced by two variant subpopulations of a rat colon cancer cell line. Int. J Cancer, 40, 87-93 (1987).
16. MCGOVERN, V.J., Spontaneous regression of melanoma. Pathology, 7, 91-99 (1975).
17. NISHIKAWA, K., LINSLEY, P.S., COLLINS, A.B., STAMENKOVIC, I., MCCLUSKEY, R.T. and ANDRES, G., Effect of CTLA-4 chimeric protein in rat autoimmune anti-glomerular basement membrane glomerulonephritis. Europ. J. Immunol., 24, 1249-1254 (1994).
18. REISSER, D., OLSSON, N.O. and MARTIN, F., In vivo and in vitro reactivity of rat spleen cells against regressor and progressor colon-cancer cell variants. Int. J. Cancer, 53, 651-656 (1993).
19. SCHWARTZ, R.H., Co-stimulation of T lymphocytes: the role of CD28, CTLA4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell, 71, 1065-1068 (1992).
20. TEPPER, M.A., LINSLEY, P.S., TRITSCHLER, D. and ESSELSTYN. J.M., Tolerance induction by soluble CTLA4 in a mouse skin transplant model. Transplant. Proc., 26, 3151-3154 (1994).
21. TURKA, L.A., LINSLEY, P.S., LIN, H., BRADY, W., LEIDEN, J.M., WEI, R.Q., GIBSON, M.L., ZHENG, X.G., MYRDAL, S., GORDON, D., BAILEY, T., BOLLING, S.F. and THOMPSON, C.B., T cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. nat. Acad. Sci. (Wash.), 89, 11102-11105 (1992).
22. WACKER, H.H., RADZUN, H.J. and PARWARESH, M.R., Ki-M2R. a new specific monoclonal antibody, discriminates tissue macrophages from reticulum cells and monocytes in vivo and in vitro. J. Leukocyte Biol., 38, 509-520 (1985).